期刊文献+

PC-1解除S6K对AKT信号通路的负反馈抑制

PC-1 Release the Negative Feedback Regulation of p70S6K on the PI3K/AKT Pathway
下载PDF
导出
摘要 目的:通过建立过表达PC-1的前列腺癌LNCaP细胞系及敲低PC-1表达的C4-2细胞系,探究PC-1激活AKT信号通路的分子机制。方法:将PC-1基因及针对PC-1的siRNA序列,分别克隆至慢病毒表达载体pCDH-EF1-Myc-MCS-T2A-Puro及干扰载体pSIH1-H1-Puro,包装成慢病毒后分别感染前列腺癌LNCaP及C4-2细胞,通过Western印迹鉴定PC-1过表达及敲低效果,并检测PI3K/AKT/mTOR信号通路相关蛋白S6K、AKT的磷酸化水平。结果:PC-1过表达时,S6K磷酸化水平下降,而AKT的磷酸化水平上升。结论:PC-1可以通过抑制S6K激酶活性,解除其对AKT的负反馈抑制作用,从而激活AKT激酶的活性。 Objective: To construct a prostate cancer LNCaP cell line stably overexpressing PC-1 and a C4-2 cell line in which PC-1 expression is stably knocked down and to explore how PC-1 active AKT pathway. Meth-ods: PC-1 and siRNA primers targeting PC-1 were separately cloned into the control vector pCDH-EF1-MCS-T2A-Puro and pSIH1-H1-Puro. Prostate cancer cells LNCaP and C4-2 cells were infected with lentivirus and the expression of PC-1 was identified by Western blot. Meanwhile, Western blot was performed to detect the phosphor-ylation level of PI3K/AKT/mTOR pathway associated proteins such as S6K, AKT. Results: PC-1 overexpression can decrease the S6K phosphorylation level, while increase AKT phophorylation level. Conclusion: PC-1 may ac-tive AKT kinase in some way through releasing negative feedback regulation of S6K on the PI3K/AKT pathway.
出处 《生物技术通讯》 CAS 2014年第4期508-510,共3页 Letters in Biotechnology
基金 国家自然科学基金面上项目(81372740 81372770)
关键词 PC-1 前列腺癌 AKT信号通路 S6K PC-1 prostate cancer PI3K/ AKT pathway S6K
  • 相关文献

参考文献8

  • 1Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008[J]. CA Cancer J Clin, 2008,58:71-96.
  • 2Wang R, Xu J, Saramaki O, et al. PrLZ, a novel prostate-spe- cific and androgen-responsive gene of the TPD52 family, am- plified in chromosome 8q21.1 and overexpressed in human prostate cancer[J]. Cancer Res, 2004,64:1589-1594.
  • 3Wang R, Xu J, Mabjeesh N, et al. PrLZ is expressed in nor- real prostate development and in human prostate canc, er pro- gression[J]. Clin Cancer Res, 2007,13:6040-6048.
  • 4Zhang H, Wang J, Pang B, et al. PC-1/PrLZ contributes to malignant progression in prostate cancer[J]. Cancer Res, 2007, 67:8906-8913.
  • 5Zhang D, He D, Xue Y, et al. PrLZ protects prostate cancer ceils from apoptosis induced by androgen deprivation via the activation of Stat3/Bcl-2 pathway[J]. Cancer Res, 2011,71: 2193-2202.
  • 6Guertin D A, Sabatini D M. Defining the role of roTOR in cancer[J]. Cancer Cell, 2007,12:9-22. .
  • 7Sarbassov D D, Guertin D A, Ali S M, et al. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex[J]. Science, 2005,307:1098-1101.
  • 8Harrington L S, Findlay G M, Gray A, et al. The TSCI-2 tu- mor suppressor controls insulin-PI3K signaling via regulation of IRS proteins[J]. J Cell Biol, 2004,166:213-223.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部